Hiroyuki Fujiki

Tolvaptan inhibits ERK-dependent cell proliferation, Cl⁻secretion, and in vitro cyst growth of human ADPKD cells stimulated by vasopressin

Gail A. Reif, Tamio Yamaguchi, Emily Nivens et al. · American Journal of Physiology-Renal Physiology · 2011 · 156 citations · Full text

Life Sciences, Cell Biology, Pharmacology +13

Tolvaptan Delays the Onset of End-Stage Renal Disease in a Polycystic Kidney Disease Model by Suppressing Increases in Kidney Volume and Renal Injury

Miki Aihara, Hiroyuki Fujiki, Hiroshi Mizuguchi et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 65 citations

Medicine, Pharmacology, Pharmacotherapy +15

Effects of Tolvaptan on Systemic and Renal Hemodynamic Function in Dogs with Congestive Heart Failure

Toshiyuki Onogawa, Yuki Sakamoto, Shigeki Nakamura et al. · Cardiovascular Drugs and Therapy · 2011 · 52 citations

Medicine, Cardiology, Veterinary Internal Medicine +14

Chronic Administration of Oral Vasopressin Type 2 Receptor Antagonist Tolvaptan Exerts Both Myocardial and Renal Protective Effects in Rats With Hypertensive Heart Failure

Hanako Morooka, Yoshitaka Iwanaga, Yodo Tamaki et al. · Circulation Heart Failure · 2012 · 52 citations · Full text

Medicine, Cardiology, Pharmacology +17

Investigation of printed wiring board testing by using planar coil type ECT probe

Hiroyuki Fujiki, M. Iwahara, Subhas Chandra Mukhopadhyay et al. · IEEE Transactions on Magnetics · 1997 · 51 citations · Full text

Engineering, Electrical Engineering, Electromagnetics +16